Research undertaken at the Ohio State University Comprehensive Cancer Center has discovered a protein presented in specific immune cells required for "optimal immune responses to cancer." According to Dr. Zihai Li, professor of medical oncology at Ohio State and principle investigator in the study, the poly(c)-binding protein 1 (PCBP1) aids in the June response that "adequate numbers of activated immune T cells differentiate into cytotoxic T cells, which kill cancer cells."
To read more about this study, click here
No comments:
Post a Comment